XOMA and Viracta Therapeutics’ Multi-License Milestone and Royalty Monetization Transaction

Martina Bellini
Tagged:

Paul Hastings LLP advised Xoma Corporation on the deal.Xoma Corporation, a biotechnology and pharmaceutical royalty aggregator announced its multi-license and milestone monetization transaction with Viracta Therapeutics. Under…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now